E
CERE

Ergoteles’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Ergoteles’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-17,405
Closed -$425K – 1654
2023
Q1 		$425K Buy
+17,405
New +$425K 0.02% 792